These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 926982

  • 1. [Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author's transl)].
    Kiesewetter E, Leodolter I, Thaler H.
    Leber Magen Darm; 1977 Oct; 7(5):318-23. PubMed ID: 926982
    [Abstract] [Full Text] [Related]

  • 2. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW, Haase W.
    Schweiz Rundsch Med Prax; 1975 Sep 09; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract] [Full Text] [Related]

  • 3. [Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)].
    Magliulo E, Gagliardi B, Fiori GP.
    Med Klin; 1978 Jul 14; 73(28-29):1060-5. PubMed ID: 353464
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J, Deák G, Müzes G, Láng I, Niederland V, Nékám K, Kárteszi M.
    Orv Hetil; 1989 Dec 17; 130(51):2723-7. PubMed ID: 2574842
    [Abstract] [Full Text] [Related]

  • 6. [Influence of (+)-cyanidanol-3 on acute hepatitis. Results of a double blind study (author's transl)].
    Rehmann I, Heinkel K.
    Med Klin; 1977 Dec 16; 72(50):2159-64. PubMed ID: 339045
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
    Trinchet JC, Coste T, Lévy VG, Vivet F, Duchatelle V, Legendre C, Gotheil C, Beaugrand M.
    Gastroenterol Clin Biol; 1989 Dec 16; 13(2):120-4. PubMed ID: 2707520
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.
    Fundam Clin Pharmacol; 2009 Jun 16; 23(3):359-65. PubMed ID: 19453758
    [Abstract] [Full Text] [Related]

  • 16. Levamisole therapy in chronic hepatitis--results of a multicentric double blind trial.
    Nilius R, Schentke U, Otto L, Teichmann W, Zipprich B, Schmidt W, Brügmann E, Busse HJ.
    Hepatogastroenterology; 1983 Jun 16; 30(3):90-2. PubMed ID: 6350136
    [Abstract] [Full Text] [Related]

  • 17. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF, Di Martino V, Dorent R, Bernard B, Hoang C, Myara A, Pauwels A, Ghoussoub JJ, Perrin M, Grippon P, Thabut D, Trivin F, Huraux JM, Gandjbakhch I, Opolon P, Lunel F.
    Transplantation; 2003 Apr 15; 75(7):977-82. PubMed ID: 12698083
    [Abstract] [Full Text] [Related]

  • 18. [Controlled study of the effect of silymarin on alcoholic liver disease].
    Bunout D, Hirsch S, Petermann M, de la Maza MP, Silva G, Kelly M, Ugarte G, Iturriaga H.
    Rev Med Chil; 1992 Dec 15; 120(12):1370-5. PubMed ID: 1343377
    [Abstract] [Full Text] [Related]

  • 19. [Therapy of chronic hepatitis (author's transl)].
    Siede W.
    Dtsch Z Verdau Stoffwechselkr; 1979 Dec 15; 39(2):57-69. PubMed ID: 378653
    [Abstract] [Full Text] [Related]

  • 20. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
    Müzes G, Deák G, Láng I, Nékám K, Niederland V, Fehér J.
    Orv Hetil; 1990 Apr 22; 131(16):863-6. PubMed ID: 2345633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.